Other Titles
Special Session
Abstract
A program of research to characterize symptoms of acute coronary syndrome, to evaluate symptoms by sex and racial/ethnic differences, and to determine if individuals cluster on specific symptoms or clinical characteristics will be described. The trajectory of the research from conceptual model to randomized clinical trial will be discussed.
Sigma Membership
Gamma Tau at-Large
Lead Author Affiliation
University of California, Los Angeles, Los Angeles, California, USA
Type
Presentation
Format Type
Text-based Document, Video Recording
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Heart Disease, Mentoring, Symptom Science, Special Populations, Ischemic Heart Disease
Recommended Citation
DeVon, Holli A., "Symptoms, sex differences, and special populations: Building the science of ischemic heart disease" (2020). INRC (Congress). 118.
https://www.sigmarepository.org/inrc/2020/presentations_2020/118
Conference Name
31st International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Virtual Event
Conference Year
2020
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Symptoms, sex differences, and special populations: Building the science of ischemic heart disease
Virtual Event
A program of research to characterize symptoms of acute coronary syndrome, to evaluate symptoms by sex and racial/ethnic differences, and to determine if individuals cluster on specific symptoms or clinical characteristics will be described. The trajectory of the research from conceptual model to randomized clinical trial will be discussed.